Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Complement C1 Inhibitor Protein MeSH Descriptor Data 2025


MeSH Heading
Complement C1 Inhibitor Protein
Tree Number(s)
D09.400.430.780
D12.644.861.140.500
D12.776.124.486.274.920.250.500
D12.776.395.320
D12.776.872.140.500
Unique ID
D050718
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D050718
Annotation
do not confuse with COMPLEMENT C1 INACTIVATOR PROTEINS
Scope Note
An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II.
Entry Version
C 1 INH
Entry Term(s)
C1 Esterase Inhibitor
C1-INH Protein
C1-Inhibitor Protein
Complement C1-Inhibitor Protein
Plasma Protease C1 Inhibitor
SERPING1
Serpin Family G Member 1
Serpin G1
Pharm Action
Complement Inactivating Agents
Registry Numbers
0
Previous Indexing
Complement C1 Inactivator Proteins (1970-2005)
Public MeSH Note
2006; for C1 ESTERASE INHIBITOR see COMPLEMENT C1 INACTIVATOR PROTEINS 1979-2005
History Note
2006; for C1 ESTERASE INHIBITOR use COMPLEMENT C1 INACTIVATOR PROTEINS 1970-2005
Entry Combination
deficiency:Hereditary Angioedema Types I and II
Date Established
2006/01/01
Date of Entry
2005/06/30
Revision Date
2023/03/16
Complement C1 Inhibitor Protein Preferred
page delivered in 0.155s